| Dr Sadia Khan, OD | |
|
8901 Wisconsin Ave, Bldg 57, Bethesda, MD 20889-0001 | |
| (301) 215-7668 | |
| Not Available |
| Full Name | Dr Sadia Khan |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 21 Years |
| Location | 8901 Wisconsin Ave, Bethesda, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235345000 | NPI | - | NPPES |
| 492091 | Other | MD | MEDICARE GROUP NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TA1936 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
Researchers from the Centre for Research in Epidemiology and Population Health in France and University College London in the UK studied more than 7,000 people over a 10-year period and show the brain's capacity for memory, reasoning and comprehension starts waning in middle age rather than in the 60s.
Diagnosis of tuberculosis is difficult in infants and young children and can be complicated by HIV infection. Heather Zar (School of Child and Adolescent Health, University of Cape Town, South Africa) and colleagues studied 250 children aged 1 month to 5 years who were admitted for suspected pulmonary tuberculosis in Cape Town. Sputum induction and gastric lavage were done on three consecutive days according to a standard procedure.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Researchers at the University of California, Davis have discovered a "cross-talk" between two major biological pathways that involve pain-research that may pave the way to new approaches to understanding and controlling chronic pain.
The Washington Post examines how high rates of malnutrition among Somali children - approximately 36 percent under age five are malnourished and almost 16 percent are severely malnourished, according to Somalia's Food Security and Nutrition Analysis Unit - are "the biggest test yet of recent improvements in assessing and treating malnutrition, changes that range from the coordination of care to the ingredients of food aid."
› Verified 8 days ago
| Provider Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
Researchers from the Centre for Research in Epidemiology and Population Health in France and University College London in the UK studied more than 7,000 people over a 10-year period and show the brain's capacity for memory, reasoning and comprehension starts waning in middle age rather than in the 60s.
Diagnosis of tuberculosis is difficult in infants and young children and can be complicated by HIV infection. Heather Zar (School of Child and Adolescent Health, University of Cape Town, South Africa) and colleagues studied 250 children aged 1 month to 5 years who were admitted for suspected pulmonary tuberculosis in Cape Town. Sputum induction and gastric lavage were done on three consecutive days according to a standard procedure.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Researchers at the University of California, Davis have discovered a "cross-talk" between two major biological pathways that involve pain-research that may pave the way to new approaches to understanding and controlling chronic pain.
The Washington Post examines how high rates of malnutrition among Somali children - approximately 36 percent under age five are malnourished and almost 16 percent are severely malnourished, according to Somalia's Food Security and Nutrition Analysis Unit - are "the biggest test yet of recent improvements in assessing and treating malnutrition, changes that range from the coordination of care to the ingredients of food aid."
› Verified 8 days ago
| Provider Name | Muslim Community Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851660526 PECOS PAC ID: 3971730946 Enrollment ID: O20140318001522 |
News Archive
Researchers from the Centre for Research in Epidemiology and Population Health in France and University College London in the UK studied more than 7,000 people over a 10-year period and show the brain's capacity for memory, reasoning and comprehension starts waning in middle age rather than in the 60s.
Diagnosis of tuberculosis is difficult in infants and young children and can be complicated by HIV infection. Heather Zar (School of Child and Adolescent Health, University of Cape Town, South Africa) and colleagues studied 250 children aged 1 month to 5 years who were admitted for suspected pulmonary tuberculosis in Cape Town. Sputum induction and gastric lavage were done on three consecutive days according to a standard procedure.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Researchers at the University of California, Davis have discovered a "cross-talk" between two major biological pathways that involve pain-research that may pave the way to new approaches to understanding and controlling chronic pain.
The Washington Post examines how high rates of malnutrition among Somali children - approximately 36 percent under age five are malnourished and almost 16 percent are severely malnourished, according to Somalia's Food Security and Nutrition Analysis Unit - are "the biggest test yet of recent improvements in assessing and treating malnutrition, changes that range from the coordination of care to the ingredients of food aid."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sadia Khan, OD 23344 Rainbow Arch Dr, Clarksburg, MD 20871-4439 Ph: (301) 963-9738 | Dr Sadia Khan, OD 8901 Wisconsin Ave, Bldg 57, Bethesda, MD 20889-0001 Ph: (301) 215-7668 |
News Archive
Researchers from the Centre for Research in Epidemiology and Population Health in France and University College London in the UK studied more than 7,000 people over a 10-year period and show the brain's capacity for memory, reasoning and comprehension starts waning in middle age rather than in the 60s.
Diagnosis of tuberculosis is difficult in infants and young children and can be complicated by HIV infection. Heather Zar (School of Child and Adolescent Health, University of Cape Town, South Africa) and colleagues studied 250 children aged 1 month to 5 years who were admitted for suspected pulmonary tuberculosis in Cape Town. Sputum induction and gastric lavage were done on three consecutive days according to a standard procedure.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
Researchers at the University of California, Davis have discovered a "cross-talk" between two major biological pathways that involve pain-research that may pave the way to new approaches to understanding and controlling chronic pain.
The Washington Post examines how high rates of malnutrition among Somali children - approximately 36 percent under age five are malnourished and almost 16 percent are severely malnourished, according to Somalia's Food Security and Nutrition Analysis Unit - are "the biggest test yet of recent improvements in assessing and treating malnutrition, changes that range from the coordination of care to the ingredients of food aid."
› Verified 8 days ago
Marc D Herwitz, OD Optometrist Medicare: Medicare Enrolled Practice Location: 8901 Rockville Pike, Bethesda, MD 20889 Phone: 301-319-7001 | |
Gregory Katchuk, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4300 East West Highway, Bethesda, MD 20814 Phone: 301-656-0775 Fax: 301-656-5164 | |
Neurovision Bethesda Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4608 S Chelsea Ln, Bethesda, MD 20814 Phone: 301-288-3975 | |
Dr. Geeta Girdher, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-2309 | |
Dr. Gail Simone Nunez-robinson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7101 Democracy Blvd, Bethesda, MD 20817 Phone: 301-469-9058 | |
Joseph Anthony Rispoli, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4975 N Palmer Rd, Bethesda, MD 20889 Phone: 301-295-0213 Fax: 304-295-6497 | |
Katharine Funari, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6430 Rockledge Dr Ste 600, Bethesda, MD 20817 Phone: 240-482-1100 Fax: 240-482-1105 |